These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9221239)

  • 21. [Patient with heart failure. Beta blockage becomes mandatory].
    Einecke D
    MMW Fortschr Med; 2000 Sep; 142(36):14-6. PubMed ID: 11021061
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta-blockade in heart failure: a potential role.
    Kwasniewski R; Clem J
    S D J Med; 1997 Jan; 50(1):25-6. PubMed ID: 9029989
    [No Abstract]   [Full Text] [Related]  

  • 23. Do standardized beta-blocker titration protocols in heart failure improve compliance? The GESICA registry experience.
    Remme WJ
    Cardiovasc Drugs Ther; 2005 Mar; 19(2):99-101. PubMed ID: 16025226
    [No Abstract]   [Full Text] [Related]  

  • 24. Carvedilol: a countermeasure to heart failure.
    Barkman A; Pooler C
    Dimens Crit Care Nurs; 2001; 20(5):11-6. PubMed ID: 22076514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carvedilol for heart failure, with care.
    Cleland JG; Swedberg K
    Lancet; 1996 May; 347(9010):1199-201. PubMed ID: 8622445
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
    Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH
    N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta blockers in severe heart failure. Prognosis improves already after a short time].
    MMW Fortschr Med; 2002 Apr; 144(15):62. PubMed ID: 12013032
    [No Abstract]   [Full Text] [Related]  

  • 28. [Incomplete and delayed parallel publication].
    Brostrøm S
    Ugeskr Laeger; 2004 Sep; 166(37):3216-7; author reply 3217. PubMed ID: 15384378
    [No Abstract]   [Full Text] [Related]  

  • 29. Carvedilol: the new role of beta blockers in congestive heart failure.
    Vanderhoff BT; Ruppel HM; Amsterdam PB
    Am Fam Physician; 1998 Nov; 58(7):1627-34, 1641-2. PubMed ID: 9824960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Beta blockers in heart failure therapy with special reference to the COPERNICUS Study].
    Hartmann F; Katus HA
    Herz; 2002 Aug; 27 Suppl 1():30-4. PubMed ID: 12229256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry.
    Franciosa JA; Massie BM; Lukas MA; Nelson JJ; Lottes S; Abraham WT; Fowler M; Gilbert EM; Greenberg B;
    Am Heart J; 2004 Oct; 148(4):718-26. PubMed ID: 15459606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of beta-blocker therapy in severe chronic heart failure.
    Negut C
    N Engl J Med; 2001 Sep; 345(13):998; author reply 998-9. PubMed ID: 11575300
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative study in heart failure. Which beta blocker saves more life time?].
    MMW Fortschr Med; 2003 Oct; 145(40):52. PubMed ID: 14603606
    [No Abstract]   [Full Text] [Related]  

  • 34. Beta blockers: are they difficult to use in heart failure patients?
    Conti CR
    Clin Cardiol; 1999 Apr; 22(4):255-6. PubMed ID: 10198734
    [No Abstract]   [Full Text] [Related]  

  • 35. The Initiation Management Predischarge Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) Study: design and implications.
    Gattis WA; O'Connor CM; Gheorghiade M
    Rev Cardiovasc Med; 2002; 3 Suppl 3():S48-54. PubMed ID: 12447162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-blocker therapy for heart failure: the standard of care.
    Cesario DA; Fonarow GC
    Rev Cardiovasc Med; 2002; 3(1):14-21. PubMed ID: 12439350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure.
    Tarantini L; Cioffi G; Opasich C; Di Lenarda A; Pulignano G; Del Sindaco D; De Feo S; Stefenelli C; Russo P; Catania G
    Ital Heart J; 2004 Jun; 5(6):441-9. PubMed ID: 15320569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective beta-blockers and mortality from heart failure.
    Seth S; Naik N; Mohan A
    Natl Med J India; 1999; 12(5):225-6. PubMed ID: 10613003
    [No Abstract]   [Full Text] [Related]  

  • 39. beta-blocker improvement in diastolic performance: the yin and yang of ventricular function changes.
    Eichhorn EJ; Grayburn PA
    Am Heart J; 2000 Apr; 139(4):584-6. PubMed ID: 10740138
    [No Abstract]   [Full Text] [Related]  

  • 40. Randomized trial of carvedilol in treatment of congestive heart failure.
    Singer RB
    J Insur Med; 1997; 29(2):82-90. PubMed ID: 10169635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.